ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 82 filers reported holding ADICET BIO INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $144,668 | -39.2% | 59,534 | +44.2% | 0.01% | -50.0% |
| Q1 2023 | $237,888 | +39.1% | 41,300 | +253.3% | 0.01% | +42.9% |
| Q2 2022 | $171,000 | -63.4% | 11,690 | -50.0% | 0.01% | -65.0% |
| Q1 2022 | $467,000 | -25.2% | 23,400 | -34.5% | 0.02% | -48.7% |
| Q4 2021 | $624,000 | +355.5% | 35,700 | +168.4% | 0.04% | +200.0% |
| Q2 2021 | $137,000 | – | 13,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |